dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pérez-Hernández, Marta |
dc.contributor.author | Cuscó, Cristina |
dc.contributor.author | Benítez-García, Cristina |
dc.contributor.author | Bonelli, Joaquin |
dc.contributor.author | Nuevo-Fonoll, Marina |
dc.contributor.author | Soriano Fernández, Aroa |
dc.contributor.author | Segura Ginard, Miguel |
dc.date.accessioned | 2022-01-20T14:09:33Z |
dc.date.available | 2022-01-20T14:09:33Z |
dc.date.issued | 2021-05-04 |
dc.identifier.citation | Pérez-Hernández M, Cuscó C, Benítez-García C, Bonelli J, Nuevo-Fonoll M, Soriano A, et al. Multi-smart and scalable bioligands-free nanomedical platform for intratumorally targeted tambjamine delivery, a difficult to administrate highly cytotoxic drug. Biomedicines. 2021 May 4;9(5):508. |
dc.identifier.issn | 2227-9059 |
dc.identifier.uri | https://hdl.handle.net/11351/6852 |
dc.description | Nanocàpsules anfòteres; Tractament del càncer de pulmó; Sistemes de lliurament de medicaments dirigits |
dc.description.sponsorship | This research was funded by Consejería de Educación de la Junta de Castilla y León (BU092U16 and BU067P20), Instituto de Salud Carlos III (grants PI18/00441 and DTS20/00018), ACCIÓ (Agency for business competitiveness; Generalitat de Catalunya) (Nuclis d’R+D EMC/2755/2017); co-funded by the European Regional Development Fund (ERDF); Asociación Española Contra el Cáncer (LABAE18009SEGU), and supported by the “Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (grant number 2013 DI 028). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Biomedicines;9(5) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Medicaments - Modes d'administració |
dc.subject.mesh | Lung Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Nanocapsules |
dc.subject.mesh | /therapeutic use |
dc.title | Multi-Smart and Scalable Bioligands-Free Nanomedical Platform for Intratumorally Targeted Tambjamine Delivery, a Difficult to Administrate Highly Cytotoxic Drug |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/biomedicines9050508 |
dc.subject.decs | neoplasias pulmonares |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | nanocápsulas |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.3390/biomedicines9050508 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pérez-Hernández M, Benítez-García C] Cancer Cell Biology Research Group (CCBRG), Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain. Oncobell Program, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, Spain. [Cuscó C, Bonelli J] Nanobiotechnological Polymers Division, Ecopol Tech, S.L., El Foix Business Park, 43720 L’Arboç del Penedès, Spain. [Nuevo-Fonoll M] Cancer Cell Biology Research Group (CCBRG), Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain. [Soriano A, Segura MF] Grup de Recerca Translacional en Càncer Infantil i Juvenil, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34064518 |
dc.identifier.wos | 000653419700001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/DTS20%2F00018 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |